Could an extra shingles shot protect transplant patients?
NCT ID NCT04128189
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well the shingles vaccine (Shingrix) works in adults with kidney failure who are waiting for a kidney transplant. Researchers want to see if giving an extra dose after the transplant boosts the immune response. About 132 participants will be followed for up to 3 years to check safety and protection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER (HZ) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
-
University of Colorado Anschutz
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which emergency dialysis saves more lives? a new study investigates
- Aging kidneys under the microscope: could a simple test predict failure?
- Can a new drug work safely in patients with kidney failure?
- Can dialysis change how a kidney drug works? a trial investigates
- AI may spot hidden kidney transplant rejection
- A drug given to organ donors may help kidneys work faster after transplant